Pharming Group N.V. (PHAR)
NASDAQ: PHAR
· Real-Time Price · USD
12.21
0.56 (4.81%)
At close: Aug 18, 2025, 10:40 AM
Pharming Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Aug 5, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 94.82M | 60.09M | 54.94M | 60.66M | 47.14M | 51.89M | 61.74M | 54.65M | 192.37M | 184.78M | 207.34M | 188.7M | 189.96M | 189.67M | 169.34M | 183.31M | 188.39M | 206.25M |
Short-Term Investments | 33.92M | 47.18M | 112.95M | 111.1M | 113.18M | 150.08M | 151.68M | 142.91M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | 8.72M | 5.92M | 4.23M | 8.71M | 8.86M | 9.18M | 11.93M | 9.24M | 9.65M | 9.77M | 9.73M | 10.78M | 11.63M | 7.4M | 8.79M | 10.01M | 7.26M | 6.71M |
Other Long-Term Assets | 95K | 1.67M | 1.59M | 93K | 90K | 90K | 92K | 1.55M | 1.81M | 1.45M | 1.33M | 407K | 969K | 1.03M | -268K | 338.69K | 493.86K | 861.63K |
Receivables | 53.33M | 47.49M | 50.17M | 48.2M | 51.12M | 38.7M | 32.07M | 40.52M | 33.16M | 32.93M | 19.58M | 28.83M | 32.88M | 31.45M | 15.88M | 32.81M | 37.57M | 32.88M |
Inventory | 63.72M | 59.35M | 55.72M | 62.23M | 59.19M | 55.88M | 56.76M | 53.44M | 53.04M | 48.13M | 42.33M | 33.51M | 33.93M | 29.61M | 24.1M | 25.1M | 24.32M | 21.73M |
Other Current Assets | n/a | n/a | n/a | n/a | n/a | n/a | 10.54M | 212K | n/a | 218K | 213K | 1.01M | 209K | 222K | 227K | 846K | 829.8K | 819K |
Total Current Assets | 245.78M | 214.11M | 278.44M | 282.19M | 270.63M | 296.55M | 316.34M | 291.74M | 278.57M | 266.06M | 277.5M | 252.05M | 256.98M | 250.95M | 220.09M | 242.19M | 251.26M | 261.82M |
Property-Plant & Equipment | 24.57M | 24.23M | 24.13M | 30.67M | 30.72M | 31.86M | 33.47M | 37.48M | 39.35M | 40.77M | 39.15M | 27.78M | 29.96M | 31.9M | 29.26M | 37.89M | 37.65M | 21.88M |
Goodwill & Intangibles | 135.9M | 138.86M | 61.04M | 67.1M | 66.57M | 68.3M | 71.27M | 69.85M | 73.41M | 75.61M | 75.12M | 70.12M | 75.77M | 81.32M | 73.97M | 89M | 91.43M | 89.78M |
Total Long-Term Assets | 200.48M | 189.07M | 121.55M | 143.32M | 145.3M | 145.12M | 154.61M | 144.73M | 151.23M | 156.94M | 148.3M | 130.28M | 136.92M | 141.85M | 130.47M | 158.71M | 160.76M | 146.74M |
Total Assets | 446.26M | 403.18M | 399.99M | 425.51M | 415.93M | 441.67M | 470.96M | 436.47M | 429.81M | 423M | 425.8M | 382.32M | 393.9M | 392.8M | 350.55M | 400.91M | 412.02M | 408.57M |
Account Payables | 78.38M | 68.75M | 10.1M | 72.64M | 72.97M | 63.49M | 8.28M | 59.16M | 54.34M | 49.09M | 6.08M | 42.74M | 43.02M | 40.83M | 5.14M | 42.15M | 43.14M | 43.6M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -3.6M | -54.46M | -5.22M | -5.18M | -5.3M | -56.23K | -4.03M | -3.93M | n/a | -44.35K | n/a | n/a | 0.00 |
Short-Term Debt | 9.56M | 4.55M | 4.25M | 3.32M | 3.15M | 134.89M | 1.82M | 1.75M | 1.8M | 1.8M | 1.77M | 1.63M | 1.73M | 1.84M | 2.42K | 4.52M | 4.62M | 4.96M |
Other Current Liabilities | n/a | n/a | 40.39M | n/a | n/a | 5.02M | 12.48M | 3.38M | 4.96M | 4.16M | 1.61M | 957.23K | 2.05M | n/a | 2.88M | -2.54M | -2.58M | 23.24M |
Total Current Liabilities | 87.94M | 77.54M | 73.8M | 79.84M | 79.94M | 207.28M | 77.97M | 68.06M | 64.95M | 59M | 59.7M | 46.69M | 49.19M | 45.15M | 41.27M | 46.72M | 47.84M | 73.71M |
Long-Term Debt | 91.27M | 83.85M | 78.15M | 92.1M | 87.32M | n/a | 123.73M | 129.73M | 134.18M | 133.58M | 122.92M | 120M | 122.4M | 135.56M | 122.13M | 140.95M | 145.5M | 140.92M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | 11.09M | n/a | 20.97M | n/a | 2.53M | 2.43M | 8.7M | 143K | 5.99M | 162K | -1.51M | 3.05M | 3.44M | 188.74K |
Total Long-Term Liabilities | 118.77M | 110.36M | 105.12M | 119.88M | 126.14M | 28.44M | 174.21M | 158.47M | 164.48M | 164.65M | 161.46M | 135.38M | 145.03M | 153.63M | 139.08M | 160.66M | 166.03M | 148.83M |
Total Liabilities | 206.71M | 187.89M | 178.92M | 199.72M | 206.08M | 235.72M | 252.18M | 226.53M | 229.43M | 223.65M | 221.16M | 182.07M | 194.23M | 198.78M | 180.34M | 207.37M | 213.86M | 222.54M |
Total Debt | 128.33M | 119.14M | 112.31M | 127.08M | 133.12M | 167.21M | 171.54M | 163.99M | 170.13M | 170.4M | 166.69M | 139.18M | 149M | 157.79M | 142.72M | 164.79M | 170.46M | 153.61M |
Common Stock | 7.82M | 7.81M | 7.77M | 7.75M | 7.75M | 7.68M | 7.67M | 7.65M | 7.54M | 7.52M | 7.51M | 7.48M | 7.47M | 7.47M | 6.42M | 7.26M | 7.25M | 7.18M |
Retained Earnings | -286.03M | -292.8M | -275.49M | -278.37M | -280.05M | -277.39M | -265.26M | -262.78M | -265.49M | -266.49M | -256.43M | -242.53M | -253.55M | -270.5M | -237.98M | -277.03M | -276.99M | -280.82M |
Comprehensive Income | n/a | 8.69M | -209K | 9.33M | -4.7M | -4M | -2.06M | -10.91M | -6.04M | -4.91M | -8.74M | -24.14M | -12.61M | -910K | 1.92M | 9.86M | 14.67M | 11.34M |
Shareholders Equity | 239.55M | 214M | 221.06M | 225.79M | 209.85M | 205.94M | 218.78M | 209.94M | 200.37M | 199.34M | 204.64M | 200.25M | 199.67M | 194.02M | 170.21M | 193.53M | 198.16M | 186.03M |
Total Investments | 42.64M | 53.1M | 117.18M | 119.82M | 122.04M | 159.26M | 163.61M | 152.15M | 9.65M | 9.77M | 9.73M | 10.78M | 11.63M | 7.4M | 8.79M | 10.01M | 7.26M | 6.71M |